Stock decliners:
AstraZeneca shares
AZN,
fell 6%. The U.K. drugmaker said its datopotamab deruxtecan treatment showed positive results in patients with advanced non-small cell lung cancer in a clinical Phase 3 trial. Analysts at UBS however pointed out the company did not quantify the progression-free benefit, which it usually does. “We suspect the PFS hazard ratio is acceptable but not great,” they added.
Shares of Tattooed Chef Inc.
TTCF,
a maker of plant-based food, plummeted 38.6% after hours on Friday after the company said that it plans to file for Chapter 11 bankruptcy protection and pursue a sale of its assets.
Shares of Chemours Co.
CC,
dropped more than 2% in the extended session Friday after the chemicals company said it would have to pay the lion’s share of a “forever chemicals” settlement alongside DuPont de Nemours Inc.
DD,
and Corteva Inc.
CTVA,
Read the full article here
